Table 2 HCV RNA response at end of therapy and end of follow up, by therapy.
HCV RNA negativity – n (%) | Group A Interferon and Ribavirin 6 mo (n = 40) | Group B Ribavirin 6 mo (n = 40) | Group C Placebo 6 mo (n = 37) |
|---|---|---|---|
end of therapy | 14 (35) 1 | 0 | 0 |
end of follow-up | 6 (15) 2 | 0 | 0 |